ClinicalTrials.Veeva

Menu

The Effectiveness of Stellate Ganglion Block in Managing Dysphagia in Patients With Medullary Infarction

A

Ahmadu Bello University Teaching Hospital

Status

Not yet enrolling

Conditions

Bulbar Palsy

Treatments

Behavioral: Comprehensive rehabilitation
Procedure: Injection
Drug: Lidocaine Hydrochloride

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

This is a randomized controlled study, including dysphagic patients with bulbar palsy after ischemic stroke who were received in the department of rehabilitation medicine. All patients are randomly allocated to the observation group or the control group. Both groups are provided with comprehensive rehabilitation. Besides, the observation group additionally undergoes the stellate ganglion block. At admission and after 10-day treatment, video fluoroscopic swallowing study, and penetration-aspiration scale, Functional Oral Intake Scale, Flexible laryngoscope are used to assess swallowing function.

Full description

Palliation of dysphagia in patients with bulbar palsy after ischemic stroke continues to be a challenge. This is a randomized controlled study, including dysphagic patients with bulbar palsy after ischemic stroke who were received in the department of rehabilitation medicine. All patients are randomly allocated to the observation group or the control group. Both groups are provided with comprehensive rehabilitation. Besides, the observation group additionally undergoes the stellate ganglion block. At admission and after 10-day treatment, video fluoroscopic swallowing study, and penetration-aspiration scale, Functional Oral Intake Scale, Flexible laryngoscope are used to assess swallowing function.

Enrollment

80 estimated patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Diagnosed with ischemic stroke according to the diagnostic criteria, with the stroke occurring in the medulla oblongata and diagnosed as bulbar palsy.
  • Upper Esophageal Sphincter did not open or opened ineffectively, with food residue or aspiration, revealed by Videofluoroscopic Swallow Study.
  • Age >18 years.
  • First-time stroke.
  • Steady vital signs,
  • Transferred or admitted to the Department of Rehabilitation Medicine within 15d after onset.

Exclusion criteria

  • The bulbar palsy caused by other diseases, such as neurodegenerative diseases.
  • Pseudobulbar palsy.
  • Complicated with other neurological diseases.
  • Tracheostomy tube inserted.
  • Simultaneously suffering from liver, kidney failure, tumors, or hematological diseases.
  • Dysphagia caused by other possible diseases.
  • Pregnant females.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

80 participants in 2 patient groups

Comprehensive rehabilitation+Stellate ganglion block
Experimental group
Description:
Patients enrolled are firstly numbered for privacy with software and divided into the observation group and the control group with. Additionally, the staffs involved in assessment would not participate in the intervention of the study. The treatment lasts 10 days.
Treatment:
Drug: Lidocaine Hydrochloride
Behavioral: Comprehensive rehabilitation
Procedure: Injection
Comprehensive rehabilitation
Active Comparator group
Description:
Patients enrolled are firstly numbered for privacy with software and divided into the observation group and the control group with. Additionally, the staffs involved in assessment would not participate in the intervention of the study. The treatment lasts 10 days.
Treatment:
Behavioral: Comprehensive rehabilitation
Procedure: Injection

Trial contacts and locations

1

Loading...

Central trial contact

Lavie Ce, Master

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems